Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093360

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093360

LAMEA Genotyping Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Kits, Instruments, and Software & Services), By Application, By End Use, By Technology, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 109 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Genotyping Market would witness market growth of 18.1% CAGR during the forecast period (2022-2028).

SNPs (single nucleotide polymorphisms) are alterations in DNA that occur at specific locations within the genome. For example, most people have a C nucleotide at a given base location in their genome, whereas a small percentage of people have an A. It indicates that there is an SNP with two potential nucleotide changes at this exact position, C or A. The human genome contains over 660 million SNPs, making them the most prevalent type of genetic differences in humans. Traits such as eye color and hereditary diseases like cystic fibrosis and sickle cell anemia, as well as serve as markers for the development of complicated diseases like diabetes and Alzheimer's disease.

By forecasting an individual's likelihood of acquiring specific diseases or designing targeted medicines tailored to the disease's genetic foundation, SNP genotyping can help usher in a new era of personalized medicine. SNP-based tests could aid in the selection of the appropriate treatment course because SNPs are linked to individual therapeutic responses.

During the first peak of the local COVID-19 outbreak, to figure out where SARS-CoV-2 came from and how it spread and evolved in the United Arab Emirates. They discovered a global clade distribution as well as eleven novel genetic variants that were nearly unknown elsewhere and designated five subclades unique to the UAE virus population. Human-to-human transmission across settlements was linked to local business activity.

The United Arab Emirates (UAE) is the first nation to authorize a Chinese COVID-19 vaccine. It is one of the world's most well-known international business and tourist centers. Even though the pandemic lasted for a long time, only a few SARS-CoV-2 samples were sequenced, and the virus's transmission and evolution trends in this area are unknown. On January 29th, 2020, the first case of SARS-CoV-2 was discovered in the country.

The Brazil market dominated the LAMEA Genotyping Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $630.4 million by 2028. The Argentina market is poised to grow at a CAGR of 18.7% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 17.8% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Reagents & Kits
  • Instruments
  • Software & Services

By Application

  • Reagents & Kits
  • Instruments
  • Software & Services

By End Use

  • Diagnostics & Research Laboratories
  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Institutes
  • Others

By Technology

  • PCR
  • Sequencing
  • Capillary Electrophoresis
  • Microarray
  • Mass Spectrometry
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific Group
  • Fluidigm Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Genotyping Market, by Product
    • 1.4.2 LAMEA Genotyping Market, by Application
    • 1.4.3 LAMEA Genotyping Market, by End Use
    • 1.4.4 LAMEA Genotyping Market, by Technology
    • 1.4.5 LAMEA Genotyping Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genotyping Market

Chapter 4. LAMEA Genotyping Market by Product

  • 4.1 LAMEA Reagents & Kits Market by Country
  • 4.2 LAMEA Instruments Market by Country
  • 4.3 LAMEA Software & Services Market by Country

Chapter 5. LAMEA Genotyping Market by Application

  • 5.1 LAMEA Diagnostics & Personalized Medicine Market by Country
  • 5.2 LAMEA Agricultural Biotechnology Market by Country
  • 5.3 LAMEA Pharmacogenomics Market by Country
  • 5.4 LAMEA Animal Genetics Market by Country
  • 5.5 LAMEA Others Market by Country

Chapter 6. LAMEA Genotyping Market by End Use

  • 6.1 LAMEA Diagnostics & Research Laboratories Market by Country
  • 6.2 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
  • 6.3 LAMEA Academic Institutes Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Genotyping Market by Technology

  • 7.1 LAMEA PCR Market by Country
  • 7.2 LAMEA Sequencing Market by Country
  • 7.3 LAMEA Capillary Electrophoresis Market by Country
  • 7.4 LAMEA Microarray Market by Country
  • 7.5 LAMEA Mass Spectrometry Market by Country
  • 7.6 LAMEA Others Market by Country

Chapter 8. LAMEA Genotyping Market by Country

  • 8.1 Brazil Genotyping Market
    • 8.1.1 Brazil Genotyping Market by Product
    • 8.1.2 Brazil Genotyping Market by Application
    • 8.1.3 Brazil Genotyping Market by End Use
    • 8.1.4 Brazil Genotyping Market by Technology
  • 8.2 Argentina Genotyping Market
    • 8.2.1 Argentina Genotyping Market by Product
    • 8.2.2 Argentina Genotyping Market by Application
    • 8.2.3 Argentina Genotyping Market by End Use
    • 8.2.4 Argentina Genotyping Market by Technology
  • 8.3 UAE Genotyping Market
    • 8.3.1 UAE Genotyping Market by Product
    • 8.3.2 UAE Genotyping Market by Application
    • 8.3.3 UAE Genotyping Market by End Use
    • 8.3.4 UAE Genotyping Market by Technology
  • 8.4 Saudi Arabia Genotyping Market
    • 8.4.1 Saudi Arabia Genotyping Market by Product
    • 8.4.2 Saudi Arabia Genotyping Market by Application
    • 8.4.3 Saudi Arabia Genotyping Market by End Use
    • 8.4.4 Saudi Arabia Genotyping Market by Technology
  • 8.5 South Africa Genotyping Market
    • 8.5.1 South Africa Genotyping Market by Product
    • 8.5.2 South Africa Genotyping Market by Application
    • 8.5.3 South Africa Genotyping Market by End Use
    • 8.5.4 South Africa Genotyping Market by Technology
  • 8.6 Nigeria Genotyping Market
    • 8.6.1 Nigeria Genotyping Market by Product
    • 8.6.2 Nigeria Genotyping Market by Application
    • 8.6.3 Nigeria Genotyping Market by End Use
    • 8.6.4 Nigeria Genotyping Market by Technology
  • 8.7 Rest of LAMEA Genotyping Market
    • 8.7.1 Rest of LAMEA Genotyping Market by Product
    • 8.7.2 Rest of LAMEA Genotyping Market by Application
    • 8.7.3 Rest of LAMEA Genotyping Market by End Use
    • 8.7.4 Rest of LAMEA Genotyping Market by Technology

Chapter 9. Company Profiles

  • 9.1 F. Hoffmann-La Roche Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.1 Recent strategies and developments:
      • 9.1.1.1 Partnerships, Collaborations, and Agreements:
  • 9.2 Danaher Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
  • 9.3 Agilent Technologies, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 Qiagen N.V.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
  • 9.7 Bio-Rad laboratories, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
  • 9.8 Eurofins Scientific Group
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Acquisition and Mergers:
  • 9.9 Fluidigm Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 LAMEA Genotyping Market, 2018 - 2021, USD Million
  • TABLE 2 LAMEA Genotyping Market, 2022 - 2028, USD Million
  • TABLE 3 LAMEA Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 4 LAMEA Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 5 LAMEA Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 6 LAMEA Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 7 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 8 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 9 LAMEA Software & Services Market by Country, 2018 - 2021, USD Million
  • TABLE 10 LAMEA Software & Services Market by Country, 2022 - 2028, USD Million
  • TABLE 11 LAMEA Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 12 LAMEA Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 13 LAMEA Diagnostics & Personalized Medicine Market by Country, 2018 - 2021, USD Million
  • TABLE 14 LAMEA Diagnostics & Personalized Medicine Market by Country, 2022 - 2028, USD Million
  • TABLE 15 LAMEA Agricultural Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 16 LAMEA Agricultural Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 17 LAMEA Pharmacogenomics Market by Country, 2018 - 2021, USD Million
  • TABLE 18 LAMEA Pharmacogenomics Market by Country, 2022 - 2028, USD Million
  • TABLE 19 LAMEA Animal Genetics Market by Country, 2018 - 2021, USD Million
  • TABLE 20 LAMEA Animal Genetics Market by Country, 2022 - 2028, USD Million
  • TABLE 21 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 22 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 23 LAMEA Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 24 LAMEA Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 25 LAMEA Diagnostics & Research Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 26 LAMEA Diagnostics & Research Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 27 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 28 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 29 LAMEA Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 30 LAMEA Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 LAMEA Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 34 LAMEA Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 35 LAMEA PCR Market by Country, 2018 - 2021, USD Million
  • TABLE 36 LAMEA PCR Market by Country, 2022 - 2028, USD Million
  • TABLE 37 LAMEA Sequencing Market by Country, 2018 - 2021, USD Million
  • TABLE 38 LAMEA Sequencing Market by Country, 2022 - 2028, USD Million
  • TABLE 39 LAMEA Capillary Electrophoresis Market by Country, 2018 - 2021, USD Million
  • TABLE 40 LAMEA Capillary Electrophoresis Market by Country, 2022 - 2028, USD Million
  • TABLE 41 LAMEA Microarray Market by Country, 2018 - 2021, USD Million
  • TABLE 42 LAMEA Microarray Market by Country, 2022 - 2028, USD Million
  • TABLE 43 LAMEA Mass Spectrometry Market by Country, 2018 - 2021, USD Million
  • TABLE 44 LAMEA Mass Spectrometry Market by Country, 2022 - 2028, USD Million
  • TABLE 45 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 LAMEA Genotyping Market by Country, 2018 - 2021, USD Million
  • TABLE 48 LAMEA Genotyping Market by Country, 2022 - 2028, USD Million
  • TABLE 49 Brazil Genotyping Market, 2018 - 2021, USD Million
  • TABLE 50 Brazil Genotyping Market, 2022 - 2028, USD Million
  • TABLE 51 Brazil Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 52 Brazil Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 53 Brazil Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 54 Brazil Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 55 Brazil Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 56 Brazil Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 57 Brazil Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 58 Brazil Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 59 Argentina Genotyping Market, 2018 - 2021, USD Million
  • TABLE 60 Argentina Genotyping Market, 2022 - 2028, USD Million
  • TABLE 61 Argentina Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 62 Argentina Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 63 Argentina Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 64 Argentina Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 65 Argentina Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 66 Argentina Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 67 Argentina Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 68 Argentina Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 69 UAE Genotyping Market, 2018 - 2021, USD Million
  • TABLE 70 UAE Genotyping Market, 2022 - 2028, USD Million
  • TABLE 71 UAE Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 72 UAE Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 73 UAE Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 74 UAE Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 75 UAE Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 76 UAE Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 77 UAE Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 78 UAE Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 79 Saudi Arabia Genotyping Market, 2018 - 2021, USD Million
  • TABLE 80 Saudi Arabia Genotyping Market, 2022 - 2028, USD Million
  • TABLE 81 Saudi Arabia Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 82 Saudi Arabia Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 83 Saudi Arabia Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 84 Saudi Arabia Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 85 Saudi Arabia Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 86 Saudi Arabia Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 87 Saudi Arabia Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 88 Saudi Arabia Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 89 South Africa Genotyping Market, 2018 - 2021, USD Million
  • TABLE 90 South Africa Genotyping Market, 2022 - 2028, USD Million
  • TABLE 91 South Africa Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 92 South Africa Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 93 South Africa Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 94 South Africa Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 95 South Africa Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 96 South Africa Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 97 South Africa Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 98 South Africa Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 99 Nigeria Genotyping Market, 2018 - 2021, USD Million
  • TABLE 100 Nigeria Genotyping Market, 2022 - 2028, USD Million
  • TABLE 101 Nigeria Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Nigeria Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 103 Nigeria Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 104 Nigeria Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 105 Nigeria Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 106 Nigeria Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 107 Nigeria Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 108 Nigeria Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 109 Rest of LAMEA Genotyping Market, 2018 - 2021, USD Million
  • TABLE 110 Rest of LAMEA Genotyping Market, 2022 - 2028, USD Million
  • TABLE 111 Rest of LAMEA Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 112 Rest of LAMEA Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 113 Rest of LAMEA Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 114 Rest of LAMEA Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 115 Rest of LAMEA Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 116 Rest of LAMEA Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 117 Rest of LAMEA Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 Rest of LAMEA Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 120 Key Information - Danaher Corporation
  • TABLE 121 key Information - Agilent Technologies, Inc.
  • TABLE 122 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 123 Key Information - Qiagen N.V.
  • TABLE 124 key information - Illumina, Inc.
  • TABLE 125 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 126 Key Information - Eurofins Scientific Group
  • TABLE 127 Key Information - Fluidigm Corporation

List of Figures

  • FIG 1 Methodology for the research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!